Boston Scientific Announces FDA Approval of TAXUS ... | 合法醫療器材資訊網

... 抑制引起硬化的物質，抑制細胞生長的物質,分子生物法，於是就發展出藥物釋放支架的新世代產品，如CYPHER® Sirolimus-eluting Coronary Stent 及TAXUS® ... Read More

Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Professionals ... Read More

The TAXUS Express Stent uses a very small but effective dose of paclitaxel, which is released slowly over the time period when restenosis is most likely to occur. Read More

TAXUS Express² Coronary Stent System · Directions for Use · Patient Guides. Read More

Use of the TAXUS Express2 Paclitaxel-Eluting Coronary Stent System is contraindicated in patients with: • Known hypersensitivity to paclitaxel or structurally- ... Read More

The TAXUS Element stent system is the thirdgeneration paclitaxel-eluting coronary stent by Boston Scientific. The most important alteration from previous TAXUS ... Read More

The two first-generation DES utilized permanent polymer coatings, with release of the drug dominated by diffusion [78]. In the Taxus stent, a coating containing ... Read More

The TAXUS Express Atom Stent is a highly deliverable drug-eluting stent (DES) specifically designed for treating small coronary vessels. It is the only DES ... Read More

由 S Tanimoto 著作 · 2007 · 被引用 13 次 — The TAXUS EXPRESS2 stent is composed of a balloon-expandable EXPRESS2 stent with a triblock copolymer coating with paclitaxel. This coating serves as a ... Read More